Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031240397Completed
Open-label, single-arm trial of midazolam, sponsored by KAKENHI. Primary endpoints: AUC of serum midazolam and Cmax of serum midazolam. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031240397.